Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACT-ACT-v6: Nab-paclitaxel and Gemcitabine in Pancreatic Cancer
NCT02707159Phase 2Completed
- Sponsor
- Stavanger University Hospital
- Start
- Nov 2014
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in pancreatic cancer (PC), sponsored by Stavanger University Hospital. Started Nov 2014; status: completed.
02
Drugs
paclitaxel
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02707159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02707159.